RE Pratley, A Salsali - Current Medical Research and Opinion®, 2007 - informahealthcare.com University of Vermont College of Medicine, Burlington, VT, USA ... Address for
correspondence: Richard E. Pratley, MD, Professor of Medicine, Director –
Diabetes & Metabolism Translational Medicine Unit, Department of Medicine, ... Cited by 29 - Related articles - BL Direct - All 4 versions
N Sadrzadeh, MJ Glembourtt, CL Stevenson - Journal of pharmaceutical sciences, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 15 - Related articles - BL Direct - All 4 versions
- ►glucagon.com [PDF] DJ Drucker - The Diabetes Educator, 2006 - tde.sagepub.com Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
Add to Technorati What's this? ... From the Banting and Best Diabetes Centre
and the University of Toronto, Toronto, Ontario, Canada. Cited by 8 - Related articles - All 6 versions
ML Fisher, JF Kapustin - Journal for Nurse Practitioners, 2007 - Elsevier The incidence of diabetes mellitus is increasing at alarming rates in the United
States which presents a management challenge for primary care practitioners.
Evidence from landmark trials such as the Diabetes Control and ... Cited by 1 - Related articles
CL Stevenson - Current Pharmaceutical Biotechnology, 2009 - ingentaconnect.com The cost of developing drugs has increased from $802 million in 2001 to $1,318
billion in 2006 [1]. The average time to develop a drug is now over 10 years,
where for every 5,000 compounds tested, 5 will make it to clinical trials ... Related articles - All 3 versions
T Elasy - Clinical Diabetes, 2008 - Am Diabetes Assoc John R. White, Jr., PA, PharmD, summarizes a new class of medications aimed at
raising endogenous levels of incretins—a class of hormones that is just being
introduced in medical school curriculums (p. 53). Although we've known for ... Related articles - All 2 versions
[CITATION] Last literature review version 17.1: Thu Jan 01 00: 00: 00 GMT 2009| This topic last …
BC Function - medscape.com Three phase 3 clinical trials have been published investigating the effects of
exenatide on patients with type 2 diabetes who did not achieve adequate glycemic
control on metformin alone, [5] a sulfonylurea alone, [6] or metformin and ... Related articles - All 2 versions
R Ghosh, V Thanawala, VJ Kadam - Current Drug Therapy, 2007 - ingentaconnect.com Abstract: With the alarming increase in the incidence of diabetes mellitus
worldwide, there is a growing need to develop new strategies to control
hyperglycemia. Currently available treatments cause various adverse effects ... Related articles - BL Direct
